Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women**Supported by the Swedish Medical Research Council grant 19x-04529 and by Sterling Winthrop Scandinavia.
- 1 July 1984
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 42 (1) , 52-57
- https://doi.org/10.1016/s0015-0282(16)47957-4
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- L‐norgestrel and progesterone have different influences on plasma lipoproteinsEuropean Journal of Clinical Investigation, 1983
- High Density Lipoprotein Subfractions during Oral and Cutaneous Administration of 17β-Estradiol to Menopausal Women*Journal of Clinical Endocrinology & Metabolism, 1983
- Effects of danazol on plasma lipid and lipoprotein levels in healthy women and in women with endometriosisAmerican Journal of Obstetrics and Gynecology, 1983
- HDL3 and HDL2 determination by a combined ultracentrifugation and precipitation procedureClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- Cholesterol, High Density Lipoprotein and DanazolJournal of Clinical Endocrinology & Metabolism, 1981
- Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.BMJ, 1981
- Effects of danazol and lynestrenol on serum lipoproteins in endometriosisClinical Pharmacology & Therapeutics, 1980
- Treatment of Post-Menopausal Hypercholerolaemia with EstradiolActa Obstetricia et Gynecologica Scandinavica, 1979
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- Evaluation of an in Vitro Assay of Lecithin:Cholesterol Acyl Transfer Rate in PlasmaScandinavian Journal of Clinical and Laboratory Investigation, 1975